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Blood flow generates shear stress on vascular endothelial cells, 
which potently regulates endothelial morphology and function, 
including cell death and growth as well as inflammatory and 
thrombotic responses. The importance of shear stress in vascular 
biology and pathophysiology is highlighted by the protective 
role of stable flow (unidirectional and high shear stress) against 
atherosclerosis  (atheroprotective)  and  the  contrasting  role  of 
unstable flow (low and oscillatory shear stress) in promoting 
atherosclerosis (proatherogenic; Nam et al., 2009).
Endothelial cells contain numerous mechanosensors that 
detect local shear stress forces and transduce them into a variety 
of cell signaling pathways (Fig. 1 A). Via these mechanosen-
sors, stable flow induces cell cycle arrest and inhibits apoptosis 
and inflammation in endothelial cells through acute and chronic 
mechanisms. Acute pathways include production of several fac-
tors, including nitric oxide (NO) from endothelial nitric oxide 
synthase (eNOS), which acts as a key mediator of the protective 
effect of stable flow. Long-term stable flow up-regulates athero-
protective genes, such as Klf2, eNOS, and antioxidant genes, 
coupled with the down-regulation of proinflammatory and pro-
atherogenic genes (Ni et al., 2010).
In contrast, disturbed flow increases endothelial apoptosis 
and proliferation, resulting in a high turnover rate that corresponds 
to hot spots of increased endothelial permeability, inflammation, 
and atherosclerosis (Chiu and Chien, 2011). The mechanism by 
which disturbed flow regulates these endothelial responses 
involves  the  production  of  reactive  oxygen  species  (ROS), 
which react with NO to form peroxynitrite and regulation of 
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proatherogenic genes (Sorescu et al., 2004; Ni et al., 2010).   
Despite intense study, however, the mechanisms by which flow 
regulates endothelial turnover are unclear.
The tumor suppressor p53 plays a crucial role in deter-
mining the fate of apoptosis or cell cycle arrest in response to 
various stresses. In response to DNA damage or stress, cells 
increase p53 levels in the nucleus to up-regulate the expression 
of proapoptotic genes or cell cycle–regulating genes (Lee and 
Bernstein, 1995; Mihara et al., 2003; Teodoro et al., 2006). The 
p53 protein is also known to induce apoptosis by a nonnuclear, 
mitochondrial-dependent mechanism. p53 binds to and inhib-
its antiapoptotic members of the Bcl-2 family that reside in the 
mitochondrial surface, such as Bcl-2 or Bcl-xL, resulting in   
increased mitochondrial membrane permeability, the release of 
mitochondrial cytochrome c into the cytosol, and the initiation of 
the apoptotic caspase cascade (Fig. 1 A; Mihara et al., 2003).
The roles of p53 in atherosclerosis and flow-sensitive en-
dothelial biology are confusing. In human atherosclerotic plaques, 
p53 expression is increased in endothelial cells, implying a role 
for p53 as an atherosclerosis-promoting factor (Ihling et al., 
1998). Also, overexpression of p53 in a transgenic mouse line 
has been shown to induce endothelial dysfunction and inflam-
mation by down-regulating transcription of klf2, an important 
antiatherogenic gene (Kumar et al., 2011). Surprisingly, however, 
p53 overexpression did not exacerbate atherosclerosis in trans-
genic mice (Sanz-González et al., 2007). To further confuse 
matters, p53 knockout enhanced atherosclerosis in mice, despite 
reducing vascular cell turnover (Guevara et al., 1999). These 
conflicting results may be caused by differential roles of p53 in 
different cell types involved in atherosclerosis, such as endothe-
lial cells, smooth muscle cells, and macrophages, or even in the 
same cell under different stress conditions (Mercer et al., 2007).
In endothelial cells, the role of p53 in flow-dependent reg-
ulation of endothelial apoptosis and cell cycle arrest has only 
been partially described. Stable flow causes cell cycle arrest in 
a p53-dependent manner by stimulating JNK-mediated phos-
phorylation of p53, which in turn up-regulates expression of the 
cell cycle–inhibitory proteins GADD45 and p21
cip1, resulting 
in cell cycle arrest (Fig. 1 B; Lin et al., 2000). However, the 
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(b) PKC is activated in flow-disturbed endothelium in the porcine 
aorta (Magid and Davies, 2005); (c) human atherosclerotic endo-
thelium shows increased levels of p53 expression (Ihling et al., 
1998); and (d) both atherosclerotic lesions and flow-disturbed re-
gions show evidence of increased levels of peroxynitrite (Patel 
et al., 2000; Hsiai et al., 2007).
To test these hypotheses, the authors developed a cone and 
plate shear device that enables the exposure of endothelial cells 
to laminar or disturbed shear stress. Using this system, they 
showed that disturbed flow phosphorylates PKC on T410 and 
T560 residues in a time-dependent manner in human umbilical 
vein endothelial cells (HUVECs). Then, they showed that disturbed 
flow induces HUVEC apoptosis by a PKC-dependent mechanism 
by using PKC siRNA or dominant-negative PKC. Next, they 
tested whether peroxynitrite produced in endothelial cells by 
disturbed flow was responsible for PKC activation and apop-
tosis. Using both chemical peroxynitrite and reagents affecting 
peroxynitrite levels (ebselen, N-nitro-l-arginine methyl ester, 
or Mn (III)tetrakis(4-benzoic acid)porphyrin chloride), they 
showed that this reactive nitrogen species mediated the activa-
tion of PKC and apoptosis. Unexpectedly, however, they found 
that neither disturbed flow nor peroxynitrite up-regulated p53 level 
and that peroxynitrite actually inhibited p53 transcription. By 
using a series of elegant molecular biological approaches and 
immunoprecipitation experiments, they determined that disturbed 
flow induced p53 SUMOylation, which led to the translocation   
of  nuclear  p53  into  the  cytoplasm  where  it  bound  Bcl-2.  p53   
SUMOylation was mediated by PKC binding to the E3 SUMO   
ligase PIASy. The binding between PKC and PIASy was then 
mapped to the C-terminal segment of the PKC kinase domain 
and the RING domain of PIASy. Surprisingly, although PIASy-
mediated SUMOylation of p53 required PKC binding, PIASy 
was not phosphorylated by PKC, indicating a phosphorylation-
independent activation of PIASy by PKC. Importantly, point 
mutations of p53 SUMOylation sites or a truncation mutant 
lacking the p53 nuclear export sequence abolished translocation   
of p53 to the cytosol and apoptosis induced by disturbed flow, 
indicating the critical importance of SUMOylation and nuclear 
export into the cytosol for p53’s apoptotic action.
These findings were validated in vivo by staining experi-
ments with flow-disturbed lesser curvature and stable greater cur-
vature regions of the mouse aortic arch. Endothelial cells in the 
lesser curvature regions show higher levels of apoptosis, total 
PKC, phosphorylated PKC, and nitrotyrosine staining, a marker 
of peroxynitrite. They also found increased perinuclear localization 
of p53 in lesser curvature regions compared with greater curvature 
regions, which is consistent with their in vitro findings.
These novel insights raise several questions: First, it is not 
clear how and where SUMOylated p53 binds to Bcl-2. The cur-
rent immunostaining study in HUVECs suggests that disturbed 
flow and peroxynitrite induce translocation of p53 into the   
cytosol, but its specific subcellular location is not clear. However, 
p53 is known to bind Bcl-2 or Bcl-xL on the mitochondrial sur-
face, leading to mitochondrial pore formation and cytochrome c 
release (Mihara et al., 2003). Whether disturbed flow works by 
this same mechanism needs to be clarified. Second, the authors 
show that p53 is only transiently SUMOylated in response to 
role of p53 in shear-induced apoptosis has not been determined.   
Now,  Heo et al. (in this issue) reports a novel mechanism by 
which disturbed flow induces apoptosis of endothelial cells via   
SUMOylation of p53 in a PKC-dependent manner.
In this work, the authors tested whether disturbed flow 
induces apoptosis by p53- and PKC-dependent mechanisms in 
endothelial cells. They further hypothesized that peroxynitrite 
produced in response to disturbed flow mediates the apoptotic 
pathway in these cells. These hypotheses were based on the 
following previous observations: (a) flow-disturbed regions 
show enhanced endothelial cell apoptosis (Zeng et al., 2009); 
Figure 1.  p53 coordinates the opposing effects of stable and disturbed 
blood flow on endothelial cell turnover. (A) A proposed pathway including 
a timeline by which disturbed flow is sensed by mechanosensors, which 
induces peroxynitrite (ONOO
) production, PKC phosphorylation, activation 
of E3 SUMO ligase PIASy, SUMOylation of p53, and its translocation to 
the cytosol, where it binds Bcl-2. Upon binding SUMOylated p53, Bcl-2 
likely releases bax, which stimulates cytochrome c release from mitochon-
dria, leading to apoptosome formation, caspase activation, and subsequent 
apoptosis. (B) Posttranslational modification of p53 (phosphorylation and 
SUMOylation under stable and disturbed flow, respectively) determines cell 
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disturbed flow (at 3 h). By 6 h, p53 is no longer SUMOylated, 
suggesting an active de-SUMOylation event. What is the under-
lying mechanism? Third, the question still remains how p53 
determines the balance between apoptosis, cell survival, and 
cell proliferation and how this ultimately controls endothelial 
cell turnover under various flow environments. Lastly, although 
the current study provides correlative in vivo evidence, cell 
type–specific knockout, knockin, or overexpression models of 
p53 in mice will be required to fully understand its role in flow-
dependent regulation of cell turnover and vascular disease.
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